BioXcel Therapeutics Cash from Investing (Quarterly) Analysis

BioXcel Therapeutics Inc (BTAI)

2.01 -0.09 (-4.29%) USD | NASDAQ | May 21, 16:00

2.00 -0.01 (-0.50%) Pre-Market: 09:07

Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
March 31, 2024	0.00
December 31, 2023	0.00
September 30, 2023	0.00
June 30, 2023	-0.02M
March 31, 2023	0.00
December 31, 2022	0.00
September 30, 2022	0.00
June 30, 2022	-0.019M
March 31, 2022	-0.12M
December 31, 2021	-0.012M
September 30, 2021	-0.017M
June 30, 2021	-0.10M
March 31, 2021	-0.316M
December 31, 2020	-0.27M

Date	Value
September 30, 2020	0.005M
June 30, 2020	-0.035M
March 31, 2020	-0.016M
December 31, 2019	-0.002M
September 30, 2019	-0.043M
June 30, 2019	-0.225M
March 31, 2019	-0.60M
December 31, 2018	-0.158M
September 30, 2018	-0.062M
June 30, 2018	-0.12M
March 31, 2018	0.00
December 31, 2017	0.00
September 30, 2017	0.00
June 30, 2017	0.00

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

-0.316M

Minimum

Mar 2021

0.005M

Maximum

Sep 2020

-0.0595M

Average

-0.0165M

Median

Cash from Investing (Quarterly) Benchmarks

Cormedix Inc	8.945M
Amicus Therapeutics Inc	7.537M
Insmed Inc	295.32M
Altimmune Inc	-39.52M
InfuSystems Holdings Inc	-0.418M

Cash from Investing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	-17.71M
Cash from Financing (Quarterly)	26.63M
Free Cash Flow	-120.36M
Free Cash Flow Per Share (Quarterly)	-0.5736
Free Cash Flow to Equity (Quarterly)	-18.74M
Free Cash Flow Yield	-201.7%